{"id":"W6921424922","doi":"10.7488/era/4945","title":"Treatment targets, real-world outcomes and optimisation of biologic therapies for the treatment of inflammatory bowel disease","year":2024,"lang":"en","type":"other","venue":"ERA","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Vedolizumab; Biosimilar; Infliximab; Adalimumab; Inflammatory bowel disease; Calprotectin; Therapeutic drug monitoring; Ulcerative colitis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008429423,0.0004438634,0.0005594012,0.0003044311,0.00003699832,0.00001945371,0.0001088226,0.0001047316,0.000339005],"category_scores_gemma":[0.0000135229,0.0002199366,0.0003082739,0.00008341484,0.0002315515,0.00002221012,0.00001842522,0.00003630127,0.00007917258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002415861,"about_ca_system_score_gemma":0.00009356975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007919566,"about_ca_topic_score_gemma":0.00103908,"domain_scores_codex":[0.9988853,0.00007415967,0.0003350649,0.000364716,0.000148499,0.0001921997],"domain_scores_gemma":[0.9987687,0.0002224024,0.0003816424,0.0005318105,0.00002977372,0.00006570714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004011358,0.006106255,0.4339663,0.004098742,0.03587604,0.0000937073,0.0186484,0.0004079588,0.00181594,0.02190303,0.410731,0.06234127],"study_design_scores_gemma":[0.002673595,0.001162579,0.1111545,0.0002218529,0.001910449,5.264579e-7,0.0002105731,0.0001556843,0.0004039643,0.001018411,0.8806394,0.0004484471],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.1077515,0.6575629,0.00008622302,0.00411343,0.003620049,0.03260284,0.04289476,0.002387719,0.1489806],"genre_scores_gemma":[0.05240703,0.03066093,0.001602221,0.0000243375,0.000399546,0.00209401,0.0006565232,0.001246349,0.9109091],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.7619285,"threshold_uncertainty_score":0.8968752,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02551247595547908,"score_gpt":0.2981720574216498,"score_spread":0.2726595814661707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}